Julian Baker

Affiliations

  • at Kiniksa Pharmaceuticals International Plc (KNSA), 2024-10-08
  • at Igm Biosciences Inc. (IGMS), 2024-10-02
  • at Incyte Corp (INCY), 2024-10-02
  • at Kymera Therapeutics Inc. (KYMR), 2024-08-22
  • at Kodiak Sciences Inc. (KOD), 2024-07-02
  • at Kala Bio Inc. (KALA), 2024-06-28
  • at Vtv Therapeutics Inc. (VTVT), 2024-06-27
  • at Madrigal Pharmaceuticals Inc. (MDGL), 2024-06-27
  • at Entrada Therapeutics Inc. (TRDA), 2024-06-26
  • at Bicycle Therapeutics Plc (BCYC), 2024-06-20
  • at Prelude Therapeutics Inc (PRLD), 2024-06-18
  • at Tscan Therapeutics Inc. (TCRX), 2024-06-14
  • at Beigene Ltd. (BGNE), 2024-06-07
  • at Acadia Pharmaceuticals Inc (ACAD), 2024-05-31
  • at Immunocore Holdings Plc (IMCR), 2024-05-29
  • Director, Other at Neurogene Inc. (NGNE), 2023-12-20
  • Director, Other at Seagen Inc. (SGEN), 2023-12-18
  • Large Shareholder at Bellicum Pharmaceuticals Inc (BLCM), 2023-11-24
  • Other at Atreca Inc. (BCEL), 2023-10-23
  • Large Shareholder, Director at Talis Biomedical Corp (TLIS), 2023-06-13
  • Large Shareholder, Director at Dbv Technologies S.a. (DBVT), 2022-06-13
  • Director at Aeglea Biotherapeutics Inc. (AGLE), 2021-06-10
  • Director at Alexion Pharmaceuticals Inc. (ALXN), 2020-05-18
  • Director at Zymeworks Inc. (ZYME), 2020-05-12
  • Large Shareholder, Director at Genomic Health Inc (GHDX), 2019-10-03
  • Large Shareholder at Idera Pharmaceuticals Inc. (IDRA), 2019-07-03
  • Other at Hookipa Pharma Inc. (HOOK), 2019-04-23
  • Large Shareholder at Principia Biopharma Inc. (PRNB), 2018-09-13
  • Large Shareholder at Invitae Corp (NVTA), 2018-03-29
  • Other at Mirati Therapeutics Inc. (MRTX), 2017-11-20
  • Other at Rhythm Pharmaceuticals Inc. (RYTM), 2017-10-06
  • Large Shareholder at Biocryst Pharmaceuticals Inc (BCRX), 2016-08-16
  • Other at Intellia Therapeutics Inc. (NTLA), 2016-05-11
  • Other at Xoma Corp (XOMA), 2015-07-23
  • Other at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Large Shareholder, Director at Ardea Biosciences Inc. (RDEA), 2012-06-21
  • Large Shareholder at Tranzyme Inc (TZYM), 2012-03-14
  • Large Shareholder at Pharmacyclics Inc (PCYC), 2012-02-14
  • Large Shareholder at Diadexus Inc. (DDXS), 2012-02-01
  • Large Shareholder at Adolor Corp (ADLR), 2012-01-03
  • Large Shareholder at Viropharma Inc (VPHM), 2011-12-16
  • Large Shareholder at Auxilium Pharmaceuticals Inc (AUXL), 2011-08-03
  • Large Shareholder at Ap Pharma Inc (APPA), 2011-07-06
  • Large Shareholder at Allos Therapeutics Inc (ALTH), 2009-02-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
IDRA $2.00 2,928,596 Director 9,309,333 2016-10-07 Filing
IDRA $2.00 321,404 Director 1,003,781 2016-10-07 Filing
INCY $62.59 90,179 Large Shareholder, Director 19,757,285 2016-03-17 Filing
INCY $62.59 9,821 Large Shareholder, Director 3,358,951 2016-03-17 Filing
INCY $61.38 127,964 Large Shareholder, Director 19,667,106 2016-03-17 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALTH $8.26 1 Large Shareholder 5,417 2009-02-06 Filing
ALTH $8.17 705 Large Shareholder 5,418 2009-02-06 Filing
ALTH $8.11 134 Large Shareholder 6,123 2009-02-05 Filing
ALTH $8.17 34 Large Shareholder 6,257 2009-02-05 Filing
ALTH $8.16 181 Large Shareholder 6,291 2009-02-05 Filing